Mesoblast raising $97.7m via Bell Potter efforts
MELBOURNE: Biotech Mesoblast had its broker Bell Potter launch a $97.7 million equity raising on
MELBOURNE: Biotech Mesoblast had its broker Bell Potter launch a $97.7 million equity raising on